Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Kelley School expert who studies causes and effects of recalls available to discuss Peloton
Peloton Interactive Inc. on May 5 announced that it is recalling its treadmills in a statement from CEO John Foley who also apologized for the company’s initial refusal to comply with federal safety regulators’ prior request for this action. George Ball, assistant professor of operations and decision technologies and Weimer Faculty Fellow at the Indiana University Kelley School of Business, studies the causes and effects of product recalls. Below are comments from Ball. He can be reached at gpball@indiana.edu. “Recall decisions like this are very difficult for managers to make, especially the ones that are high profile and associated with consumer injury. Managers have to balance the firm financial health with consumer safety. Thus, this is a rich area of research. The research that my colleagues and I undertake in this field deal both with the regulator and the firm. My comments will attempt to address both perspectives. “I will start with the regulator. I am currently involved in a research project with two colleagues that is specifically critiquing the Consumer Product Safety Commission for situations very similar to this Peloton recall. There are three main regulators in the US that oversee product quality and in particular recalls: the FDA, NHTSA and the CPSC. “Of those, CPSC is the least proactive and in my view, least successful in properly managing product recalls and their timeliness. This is because there are two main ways in which a firm can push firms to recall; they can force them to, or they can work with the firm management to help encourage them, or nudge them, to recall. The FDA is very good at influencing firms while NHTSA is quite good at mandating recalls. CPSC does neither well. “In particular, the FDA frequently chooses to use their relationships with senior quality executives at firms to nudge them to recall when FDA feels it may be necessary and the firm has not yet acted upon the quality problem. Conversely, NHTSA mandates approximately 20 to 30 percent of auto recalls, such that they choose to force instead of nudge. However, in both cases, while neither industry (medical products and autos) are perfect when it comes to recall timeliness, and both have suffered unfortunate well-known examples of firms dragging their feet in the recall decision, both have a well-developed approach. “CPSC mandates practically no recalls and they do not, from my research, have strong relationships with firm executives that can help them nudge firms to make the quick recall decision. Thus, this Peloton example is one of many in which consumer product firms may take too long to recall. “From the firm perspective. There are several potential red flags that may indicate the firm took too long. The longer a consumer product industry CEO has been in their role, the slower they are to make recall decisions. This is because the longer a CEO is in the role, the less open they are to taking responsibility for such high-profile mistakes. Interestingly, a new CEO, such as one who has been in their role for two to three years, is much more likely to recall a faulty product. “The CEO of Peloton definitely falls into the category of a fairly long-tenured CEO who has his reputation tied closely to the firm’s success. Secondly, the more stock a CEO owns in their firm, the slower they are to make the recall decision, because they are trying to protect their financial welfare. The CEO of Peloton appears to have a significant fortune at stake in Peloton stock, which would be consistent with our research. The more stock a CEO owns, the slower the firm take to recall defective products.”
New CBS Sitcom "United States of Al" Taps Experience of Social Work Student and Veteran
On April 1, 2021, CBS premiered United States of Al - a new comedy from producer Chuck Lorre (Two and a Half Men, Big Bang Theory) about a Marine combat veteran struggling to readjust to civilian life and the interpreter who served with his unit in Afghanistan and has just arrived to start a new life in America. The show explores the relationship between these two men and how they help each other adjust to their new lives. So, what does a CBS sitcom have to do with the USC Suzanne Dworak-Peck School of Social Work? Enter Master of Social Work (MSW) student Josh Emerson, who landed in the right place at the right time through his field internship at No One Left Behind. No One Left Behind (NOLB) is an all-volunteer, national nonprofit organization that supports recipients of the Special Immigrant Visa (SIVs), and those pursuing an SIV. The founders of No One Left Behind believe the U.S. has a moral obligation to protect these interpreters, and their families, who served side-by-side with American soldiers. Emerson, a veteran of the U.S. Army who deployed to Iraq and Afghanistan, is very familiar with Iraqi and Afghan interpreters. “I went on missions with these interpreters, got to know them, built relationships with them,” he said. “I was so very happy to be able to work with them in this capacity. In addition to providing resources for SIV ambassadors living in the United States, NOLB advocates on behalf of the SIV population to the executive and legislative branches of government provides subject matter expertise to the media, and partners with U.S. businesses to provide opportunities for what they call “this next generation of Americans.” Alea Nadeem, MSW ’15, is a board member of NOLB and reached out to USC with a field internship opportunity for social workers to do macro-level clinical work in a nonprofit setting. Nadeem became Emerson’s field instructor. “What Josh has brought to No One Left Behind has never been brought to the board before,” Nadeem said. “They now see the value in social work.” Bringing the issue to a larger audience Chase Millsap, a consultant and writer on United States of Al, is a former board member of No One Left Behind. “I am still very supportive, impressed and proud of all the work the NOLB team does on a daily basis,” he said. A veteran of the U.S. Marine Corps and U.S. Army Special Forces, he holds a master’s degree from USC Sol Price School of Public Policy. "USC helped me to learn the tools about how to connect entertainment and policy,” Millsap said. “United States of Al is a perfect example of those two worlds coming together in a powerful (and funny) way.” Millsap’s idea was to bring the issues around SIVs into America's living rooms, in a way that would make them relatable. Emerson’s experience as a veteran, his clinical and project management skills obtained through his social work studies and his stellar ability to work one-on-one with SIV recipients and applicants allowed him to inform the show’s stories with a wide breadth of knowledge. Emerson joined James Miervaldis, chairman of the NOLB board, in helping the writers and actors on the show understand the SIV issues, the ways in which NOLB provides assistance and advocacy, and sharing funny stories of cultural differences between Afghans and Americans. Emerson and Miervaldis have also been able to include some of NOLB’s SIV ambassadors in the process, those with an SIV who have already established themselves in the U.S. and are contracted by NOLB to help others assimilate. “They’re talking to the exact people they're portraying,” Emerson said. Nadeem sees Emerson’s contribution to the show as another platform through which to educate. “There are a lot of different tentacles to social work, and it may not seem like the most obvious place in TV and film, but it is,” she said. The show itself touches on everything social workers value ― service, challenging social injustice, dignity and worth of a person, the importance of human relationships and integrity. “This just makes so much sense that a social worker would be involved in this show because that's what we're always trying to communicate to a larger audience,” Nadeem said. “Through this show, you can make a greater impact for these folks to sort of assimilate them to be American citizens, and then also have the whole world appreciate their culture and appreciate what they've done for our nation to keep U.S. service members safe.” A valued member of the team Emerson, a father of five who resides in New Hampshire, knew he wanted to work with veterans after leaving military service. He felt that an MSW was the most versatile degree for this and chose the USC Suzanne Dworak-Peck School of Social Work because of its military social work track. “I think to be a good social worker you need to have experience in life,” Emerson said. “To have seen some things, or been through some things, to understand the population you're dealing with and what they're going through.” When Emerson began his internship at NOLB in 2020, Miervaldis immediately began working with him to focus on SIVs who recently had come to the United States. The first case Miervaldis assigned to Emerson was an SIV family with two young children who needed emergency surgery at a specialty hospital in Washington D.C. “This SIV packed up his family, his pregnant wife and the two kids, used up all his money to take them by bus from Texas to D.C. in the middle of a pandemic and ended up in a bad part of town,” Miervaldis said. As the SIV’s assigned caseworker, Emerson established a relationship and trust with the SIV, helped him obtain safe housing and a job interview, and coordinated details for the children’s surgery with the hospital. “He’s gone and done everything,” Miervaldis said. “We are very proud of Josh’s initiative and empathy for a family in such need. No One Left Behind is the safety net for our allies.” Last year, NOLB helped over 600 families with visas and resettlement. “Josh has exceeded all our expectations and done so while communicating with clients who speak in broken English, Dari and Pashtu, struggling during a pandemic,” Miervaldis said. “His professionalism and empathy are great credits to USC. We would not be where we are today without him. That is not hyperbole.” Miervaldis hopes NOLB will have more social work interns from USC to continue Emerson’s work. For him, Emerson’s project management skills have been the greatest asset, creating a new process for how NOLB provides help for SIV families. “We told Josh, you're a pathfinder, you're a pioneer,” Miervaldis said. “We need to figure out very quickly what works, what doesn't work, and he took it and said, ‘okay, point me in the right direction.’ He’s very much valued as a member of the team.” From advocacy to TV No One Left Behind gets about 20 messages every day from Iraqi or Afghan interpreters who served with U.S. forces in their countries, and who now receive daily death threats from the Taliban. “They're not allowed to live in their homes or their neighborhoods anymore because they helped the U.S.,” Emerson said. “Now the U.S. is withdrawing from all these countries, and the Taliban and terrorist activities in general are picking up, and these people are getting pressured and killed. NOLB has over 300 cases of SIVs who have been killed waiting for their visas.” Emerson hopes that the added exposure from United States of Al will bring awareness particularly to service members about what these interpreters are experiencing and how they can help. One of the requirements for an SIV is a letter of recommendation from the U.S. service member with whom they served, and those have been the most difficult items for SIV applicants to secure. “I have been able to provide some input to what should be addressed in the show,” Emerson said. “It's interesting to see how advocacy on an issue can turn into something this large scale.” See more news from USC Suzanne Dworak-Peck here.
The Food and Drug Administration and the Centers for Disease Control and Prevention recently lifted the pause on the Johnson & Johnson COVID-19 vaccine. The agencies had shelved the vaccine after it was linked to cases of an extremely rare blood clotting disorder. Public health officials are now concerned that as news gets out about the potential side effects of the Johnson & Johnson vaccine, some members of the Black and Hispanic communities may opt out of what could be a life-saving act. “To the Black and Hispanic communities, there has been a long history of untrustworthy behavior by health care systems, and the current issue with Johnson & Johnson may have worsened some hesitancy,” said Dr. Justin X. Moore, an epidemiologist in the Department of Population Health Sciences at the Medical College of Georgia. “To overcome this barrier, companies must continue being open about side effects of the vaccine, and health care workers must be empathetic and listen to their patients’ concerns.” Vaccine safety and the importance of everyone being vaccinated is crucial as America looks to get to the light at the end of this pandemic. If you are a journalist covering COVID-19 and the issues surrounding vaccine hesitancy, then let our experts help. Dr. Justin Moore is an expert in spatial epidemiology and an associate professor at the Institute of Public and Preventive Health at Augusta University. He is available to speak with media regarding this topic – simply click on his name to arrange an interview.
MEDIA RELEASE: CAA supports provincial efforts to move Ontarians more safely
CAA South Central Ontario supports today’s provincial announcement of the Moving Ontarians More Safely & Towing and Storage Safety and Enforcement Act, 2021. The proposed legislation is an important step toward addressing the needs and challenges experienced by both motorists and the towing industry. “CAA is pleased that provincial legislation to govern the towing industry looks to address the most pressing issues related to safety and consumer confidence,” says Teresa Di Felice, AVP government and community relations, CAA SCO. “Provincial oversight should provide consistent levels of training for operators, create standards for this important service on Ontario roads and establish tough penalties for those who do not follow the rules.” One element highlighted in today’s announcement is the introduction of a tow truck licensing system. “CAA’s research on this demonstrates that motorists expect their tow operators to be provincially licensed and qualified to perform towing services safely,” adds Di Felice. The tougher enforcement measures for stunt driving are also welcome. Since the COVID-19 lockdown measures first began in March 2020, police have seen a significant surge in speeding and street racing—both of which can have serious consequences. “The dangerous driving behaviours that we have seen over the past year highlights the need for increased measures, education and enforcement. The proposed changes will help to continue making Ontario’s streets some of the safest in North America,” adds Di Felice. A study commission by CAA SCO in March highlighted that 74 per cent of drivers agree that stricter penalties and increased fines would discourage drivers from performing stunts or driving aggressively. CAA believes that safer streets for all Ontarians are possible. This new proposed legislation will not only bring clarity for consumers when requesting towing services, the tougher penalties for stunt driving will help to curb the impulse to speed or drive dangerously. The study was conducted between March 15th to 22nd, 2021, among a sample of 1,504 Ontario driver’s license (G, G2 or G1) holders, have access to a vehicle and are part of the Asking Canadians’ research panel. The study was conducted through online surveys. A probabilistic sample of a similar size would have a margin of error of plus or minus 3%, 19 times out of 20.
Novel coronavirus discovered in British bats
A coronavirus related to the virus that causes Covid-19 in humans has been found in UK horseshoe bats – according to new collaborative research from the University of East Anglia, ZSL (Zoological Society of London), and Public Health England (PHE). However, there is no evidence that this novel virus has been transmitted to humans, or that it could in future, unless it mutates. UEA researchers collected faecal samples from more than 50 lesser horseshoe bats in Somerset, Gloucestershire and Wales and sent them for viral analysis at Public Health England. Genome sequencing found a novel coronavirus in one of the bat samples, which the team have named ‘RhGB01’. Due to the rapid response nature of this research, it has not yet been peer reviewed. It is the first time that a sarbecovirus (SARS-related coronavirus) has been found in a lesser horseshoe bat and the first to be discovered in the UK. The research team say that these bats will almost certainly have harboured the virus for a very long time. And it has been found now, because this is the first time that they have been tested. Importantly, this novel virus is unlikely to pose a direct risk to humans, unless it mutates. A mutation could happen if a human infected with Covid-19 passes it to an infected bat, so anyone coming into contact with bats or their droppings, for example those engaged in caving or bat protection, should wear appropriate PPE. Prof Diana Bell, an expert in emerging zoonotic diseases from UEA’s School of Biological Sciences, said: “Horseshoe bats are found across Europe, Africa, Asia and Australia and the bats we tested lie at the western extreme of their range. “Similar viruses have been found in other horseshoe bat species in China, South East Asia and Eastern Europe. “Our research extends both the geographic and species ranges of these types of viruses and suggests their more widespread presence across more than 90 species of horseshoe bats. “These bats will almost certainly have harboured this virus for a very long time – probably many thousands of years. We didn’t know about it before because this is the first time that such tests have been carried out in UK bats. “We already know that there are different coronaviruses in many other mammal species too,” she said. “This is a case of ‘seek and you will find’. “Research into the origins of SARS-CoV-2, the virus that causes Covid-19 in humans, has focussed on horseshoe bats - but there are some 1,400 other bat species and they comprise 20 per cent of known mammals. “Our findings highlight the need for robust genotype testing for these types of viruses in bat populations around the world. And it raises an important question about what other animals carry these types of viruses.” Prof Andrew Cunningham, from the Zoological Society of London, said: “Our findings highlight that the natural distribution of sarbecoviruses and opportunities for recombination through intermediate host co-infection have been underestimated. “This UK virus is not a threat to humans because the receptor binding domain (RBD) – the part of the virus that attaches to host cells to infect them - is not compatible with being able to infect human cells. “But the problem is that any bat harbouring a SARS-like coronavirus can act as a melting pot for virus mutation. So if a bat with the RhGB01 infection we found were to become infected with SARS-CoV-2, there is a risk that these viruses would hybridise and a new virus emerge with the RBD of SARS-CoV-2, and so be able to infect people. “Preventing transmission of SARS-CoV-2 from humans to bats, and hence reducing opportunities for virus mutation, is critical with the current global mass vaccination campaign against this virus.” Prof Bell added: “The main risks would be for example a bat rehabilitator looking after a rescued animal and infecting it with SARS-CoV2 - which would provide an opportunity for genetic recombination if it is already carrying another sarbecovirus. “Anyone coming into contact with bats or their droppings, such as bat rescuers or cavers, should wear appropriate PPE – in order to reduce the risk of a mutation occurring. “We need to apply stringent regulations globally for anyone handling bats and other wild animals,” she added. The new virus falls within the subgroup of coronaviruses called sarbecoviruses which contains both SARS-CoV-2 (responsible for the current pandemic) and SARS-CoV (responsible for the initial 2003 SARS outbreak in humans). Further analysis compared the virus with those found in other horseshoe bat species in China, South East Asia and Europe and showed that its closest relative was discovered in a Blasius’s bat from Bulgaria in 2008. Ivana’s story The UK discovery was made by undergraduate ecology student Ivana Murphy, from UEA’s School of Biological Sciences, who collected bat droppings as part of her final year research dissertation. Jack Crook conducted the genetic analyses in partnership with other researchers at PHE. A total of 53 bats were captured, and their faeces collected in sterile bags. The research was conducted under strict Health and Safety protocols. Full PPE was worn and Ivana was regularly tested for Covid-19 to avoid any chance of cross contamination. The bats were released immediately after their droppings had been collected. Ivana said: “I am very fortunate to be surrounded by so many experts in their fields, which has allowed me access to resources that many undergraduates wouldn’t have. I feel extremely lucky to have been able to conduct such an advanced study.” “We weren’t shocked by the results, but I am extremely eager to carry out further research. “I chose to study ecology at UEA as I have a passion for trying to protect and conserve nature. I wanted a better understanding of the global situation and so chose UEA to study ecology and conservation. “The plan after graduation is to do an extended study of viruses in UK bats, very similar to the one I carried out as an undergraduate. There is still a lot more to understand and I am extremely excited to see what else we can find out.” But she says that she doesn’t want her research to turn people against bats. “More than anything, I’m worried that people may suddenly start fearing and persecuting bats, which is the last thing I would want and would be unnecessary. As like all wildlife, if left alone they do not pose any threat.” ‘Metagenomic identification of a new sarbecovirus from horseshoe bats in Europe’ is published on the Research Square pre-print server. Read the full story, including a Q&A with all you need to know.
The Zoom Boom? More and more Americans are getting plastic surgery – let our expert explain why
After almost a year where most American offices went unused, experts are noticing an unexpected side effect from all those online meetings. It appears that prolonged exposure to seeing yourself in that tiny box during video calls is inspiring a sudden uptick in plastic surgery. The plastic surgery industry is booming during the coronavirus pandemic, largely due to the increase in the number of virtual meetings offered through Zoom and other video web services. Call it the “Zoom boom.” The interest in cosmetic surgery is boosting appointments for Botox, lip fillers and other plastic surgery procedures that help people feel more attractive on computer screens, according to Dr. Maria Helena Lima, an assistant professor of Surgery for the Section of Plastic and Reconstructive Surgery in the Medical College of Georgia at Augusta University. “In the last few months, there has been a jump in the number of patients wanting plastic surgery procedures,” said Lima. “We have discovered that when people are in Zoom meetings, they should be listening to the content and paying attention to what’s going on, but they’re not.” Lima says participants are oftentimes looking at themselves on the screen and wondering what could be done to alter their image. It is a trend that offers up some interesting questions: • Along with the Zoom boom, are there other reasons people are opting to go under the knife for an elective procedure? • Are there long-term consequences to these decisions? • What do patients need to know first to avoid any safety or health issues? There’s a lot to know about this topic, and if you are a journalist looking to learn more, then let us help with your coverage. Dr. Maria Helena Lima is one of the nation’s leading plastic surgeons with 12 years of experience specializing in aesthetic plastic surgery, facial reconstruction and craniofacial pediatric plastic surgery. She is available to speak with media about this emerging trend. Simply click on her name now to arrange an interview today.
Kids in School: 3 Feet Apart or 6 Feet?
The Centers for Disease Control and Prevention (CDC) recently published updated guidelines for elementary schools, "now [recommending] that, with universal masking, students should maintain a distance of at least 3 feet in classroom settings" as opposed to the previous recommendation of 6 feet. While many have had strong reactions for and against this updated guidance, immunologist Joseph Comber, PhD, an associate teaching professor of biology at Villanova University, wants to add nuance to the conversation. On the one hand, Dr. Comber notes, when the CDC updates health and safety guidelines, the public can trust that as more information and data become available, the science behind the updates becomes more accurate. He stresses that studies "showed no difference in transmission between kids kept 3 feet apart or 6 feet apart in schools." Plus, Comber says, "we already know that kids younger than 10 and 11 are less likely to spread the virus than older kids and adults." However, Dr. Comber cautions that the subjects of the study followed "strict mask guidance and adherence to masking. We don't know what happens if schools enforce 3 feet of distance but are not strict with masking." He also points out that where the study was done can have an impact on the results. Comber emphasizes that "community spread is most important to the specific community and, as we've seen so far, different states and regions can spike with infections at different times." He wonders "if this is especially true in areas that have higher virus circulation than others." Dr. Comber notes that these guidelines are for elementary schools only, with one rather large caveat: "children are increasingly being infected." Another concern with these shifting regulations is whether they will impact public trust. Villanova professor Jie Xu, PhD, is an expert on science and health communications. Her concern about this change is minimal "because science is evolving." She emphasizes that "we need to be able to revise conclusions when new evidence comes in," and she sees the country's "highly politicized environment" as something to be taken more seriously, when it comes to public health. Dr. Xu cites "rising distrust in authorities and institutions (which has been going on for quite some time)" and notes that, when it comes to the nation’s children, in-person versus virtual schooling is a "highly charged issue." In the end, according to Dr. Comber, "it remains to be seen what happens when kids are packed 3 feet into classrooms on a broad scale."
MEDIA RELEASE: After a one-year hiatus, the annual CAA Worst Roads campaign returns
With a renewed focus on education and safety, CAA South Central Ontario (CAA SCO) is proud to announce that following a one-year hiatus due to COVID-19, the annual CAA Worst Roads Campaign is back, and voting is now open. “The campaign is a platform for all road users to highlight which roadway improvements should be prioritized by our different levels of government,” says Raymond Chan, government relations manager CAA SCO. “The campaign gives decision-makers a snapshot of what roads the public perceives are not meeting their expectations.” Over the course of the last year people have changed their transportation habits. More people are cycling or driving their vehicles instead of carpooling and using public transit. CAA believes funding for roadway improvements needs to be consistent to ensure that quality and safety is maintained. “Our roads are essential, they are the arteries used every day to keep workers, goods and services flowing and should be maintained more than ever,” adds Chan. “As people are encouraged to stay home and telework during the pandemic, governments should continue to take advantage of lighter traffic patterns as an opportunity for road repair. These efforts can also be refocused on increasingly popular modes of transportation, such as cycling and walking.” Investing in infrastructure improvements, including the proper maintenance of roads and bridges, is important to the vitality and economic recovery of local communities. CAA continues to advocate for longer-term dedicated infrastructure funding to help municipalities prepare, plan, budget and execute on repair backlogs and capital projects. The success stories over the last 17 years are a result of governments prioritizing infrastructure through multi-year capital investments. Some examples include: 1. Riverdale Drive, Washago Despite appearing on the CAA Worst Roads list for the first time in 2019, the poor road conditions of Riverdale Drive was not new to residents of Severn. After 20 years since the street’s last resurfacing, Council approved $50,000 of prep work for Riverdale Drive led by Ward 5 Councillor Sarah Valiquette. 2. Dufferin Street, Toronto Appearing on the provincial top 10 list annually since 2015, Dufferin Street between Bloor Street and Dundas Street underwent resurfacing from September to November 2018. An estimated 35,000 vehicles travel Dufferin Street daily and the number of commuters is increasing. In response to community concerns, Toronto City Council adopted a motion to expedite studies relating to pedestrian and cyclist safety along Dufferin Street, among other improvements in December 2020. 3. College Road, Windsor The intersection of Campbell and College Avenue underwent sewer, road and water main rehabilitation in May 2019. College Avenue between South Street and Brock Street was repaired in November 2019. CAA is calling on all Ontarians to vote for their Worst Roads today and join the community of drivers, cyclists, transit riders and pedestrians committed to improving Ontario’s roads. Nominations for CAA’s Worst Roads can be cast at caaworstroads.com until April 18. To encourage participants to act on their concerns, they will be entered into a grand prize draw to win free gas for a year, or one of 5 secondary prizes. Once voting closes, CAA will compile a list of the 10 Worst Roads in Ontario, along with the Worst Roads in regions across the province. The regional top five lists will help shine further light on the state of local roads in municipalities across Ontario. CAA will present the list of 2021 Worst Roads to local and provincial officials to help inform future funding and planning decisions. Here is a roundup of Ontario's Top 10 Worst Roads in 2019: 1. Eglinton Avenue East, Toronto 2. Riverdale Drive, Washago 3. Dufferin Street, Toronto 4. County Road 49, Prince Edward 5. Barton Street East, Hamilton 6. Burlington Street East, Hamilton 7. Avondale Road, Belleville 8. Sheppard Avenue East, Toronto 9. Carnegie Beach Road, Scugog 10. Bathurst Street, Toronto
Ask the Expert: Vaccine myths and scientific facts
Now that there are authorized and recommended COVID-19 vaccines, it is critical people receive accurate information. Peter Gulick, professor of medicine at the Michigan State University College of Osteopathic Medicine and infectious disease expert, reviews some myths about the vaccine and counters these with scientific facts. Myth: The COVID-19 vaccines were developed in a rush, so their effectiveness and safety can’t be trusted. Fact: Studies found that the Pfizer/BioNTech and Moderna are both about 95% effective compared to the influenza vaccine, which ranges from being 50% to 60% effective each year. The Johnson & Johnson vaccine is 85% effective at curbing serious or moderate illness. The most important statistic is that all three were 100% effective in stopping hospitalizations and death. As of March 9, 2021, the Centers for Disease Control and Prevention reports that 93.7 million people have been vaccinated and all safety data collected from these doses show no red flags. There have been about 5 cases of anaphylaxis, an allergic reaction, per 1 million but this is no different than allergic reactions from other vaccines. There are many reasons why the COVID-19 vaccines could be developed so quickly and here are a few: The COVID-19 vaccines from Pfizer/BioNTech and Moderna were created with a messenger RNA technology that has been in development for years, so the companies could start the vaccine development process early in the pandemic. China isolated and shared genetic information about COVID-19 promptly so scientists could start working on vaccines. The vaccine developers didn’t skip any testing steps but conducted some of the steps on an overlapping schedule to gather data faster. The Pfizer/BioNTech and Moderna vaccines were created using messenger RNA, or mRNA, which allows a faster approach than the traditional way that vaccines are made. Because COVID-19 is so contagious and widespread, it did not take long to see if the vaccine worked for the vaccinated study volunteers. Companies began making vaccines early in the process — even before FDA authorization — so some supplies were ready when authorization occurred. They develop COVID-19 vaccines so quickly also due to years of previous research on the SARS COV-1, a related virus. Myth: The messenger RNA technology used to make the Pfizer/BioNTech and Moderna COVID-19 vaccine is brand new. Fact: The messenger RNA technology behind these two vaccines has been studied and in development for almost two decades. Interest has grown in these vaccines because they can be developed in a laboratory using readily available materials, making vaccine development faster. mRNA vaccines have been studied before for flu, Zika and rabies. Myth: You only need one dose of J&J vaccine so it’s more effective. Fact: Johnson & Johnson’s vaccine uses a different strategy — a weakened cold virus that is reprogrammed to include the code for the spike protein. Once inside the body, the viral genes trigger a similar response against the virus. All three vaccines are considered overall effective and 100% effective in preventing hospitalizations and death. Myth: Vaccine efficacy and effectiveness mean the same thing. Fact: Efficacy and effectiveness do not mean the same thing. “Efficacy” refers to the results for how well a drug or vaccine works based on testing while “effectiveness” refers to how well these products work in the real world, in a much larger group of people. Most people, however, use them interchangeably even though they have different scientific meanings. Myth: The vaccines aren’t effective against new strains of the virus. Fact: Currently, we know both the U.K. strain as well as the South African variant have increased transmissibility of 30% to 50% over the natural strain. As far as an increase in causing more serious disease, it is not known yet. We have over 600 U.K. variants in Michigan and one case of the South African variant, and I just heard of 47 cases of the U.K. variant in Grand Ledge. We (Michigan) are second in the nation in variants, but that's likely because we test for them more. The most important information is that the vaccines, in general, are 100% effective in prevention of hospitalization and death. So, it is felt they all offer some protection against variants to prevent serious disease. As far as the Johnson & Johnson, it was used with variants and has efficacy overall of 72% in U.S., 66% in Latin America and 57% in South Africa (where the main strain is the South African variant). All companies are looking at modifying (their products) (the mRNA) to cover variants and either give a booster or a multivalent vaccine to cover all variants. Myth: There are severe side effects of the COVID-19 vaccines. Fact: The COVID-19 vaccine can have side effects, but the vast majority go away quickly and aren’t serious. The vaccine developers report that some people experience pain where they were injected; body aches; headaches or fever, lasting for a day or two. This is good and are signs that the vaccine is working to stimulate your immune system. If symptoms persist beyond two days, you should call your doctor. Myth: Getting the COVID-19 vaccine gives you COVID-19. Fact: The vaccine for COVID-19 cannot and will not give you COVID-19. The two authorized mRNA vaccines instruct your cells to reproduce a protein that is part of the SARS-CoV-2 coronavirus, which helps your body recognize and fight the virus, if it comes along. The COVID-19 vaccine does not contain the SARS-Co-2 virus, so you cannot get COVID-19 from the vaccine. The Johnson & Johnson vaccine was developed using adenovirus vector technology and also will not give you COVID-19. It shows your immune system a weakened, common cold virus “disguised” as the coronavirus instead. Adenovirus vaccines have been around for about two decades, the same as mRNA vaccines. Johnson & Johnson developed a vaccine for Ebola using this technology. Myth: The vaccines are ineffective against the virus variants. Fact: More time is needed to study the vaccines’ effectiveness against the variants. Studies are now being conducted to determine if a booster dose is needed to protect against the variants or if modifications to the vaccines are needed. Myth: I already had COVID-19 and I have recovered, so I don't need to get the vaccine. Fact: There is not enough information currently available to say if or for how long after getting COVID-19 someone is protected from getting it again. This is called natural immunity. Early evidence suggests natural immunity from COVID-19 may not last very long, but more studies are needed to better understand this. The CDC recommends getting the COVID-19 vaccine, even if you’ve had COVID-19 previously. However, those that had COVID-19 should delay getting the vaccination until about 90 days from diagnosis. People should not get vaccinated if in quarantine after exposure or if they have COVID-19 symptoms. Myth: I won't need to wear a mask after I get the vaccine. Fact: It may take time for everyone who wants a COVID-19 vaccination to get one. Also, while the vaccine may prevent you from getting sick, more research is needed, but early indications show that while the vaccine is effective in reducing transmission, it is possible for a vaccinated person to spread the virus. Until more is understood about how well the vaccine works, continuing with precautions such as mask-wearing and physical distancing will be important. Myth: COVID-19 vaccines will alter my DNA. Fact: The COVID-19 vaccines will not alter any human genome and cannot make any changes to your DNA. The vaccines contain all the instructions necessary to teach your cells to make SARS-CoV-2's signature spike protein, release it out into the body, and your immune system gets a practice round at fighting off COVID-19. Myth: The COVID-19 vaccine can affect women’s fertility Fact: There is currently no evidence that antibodies formed from COVID-19 vaccination cause any problems with pregnancy, including the development of the placenta. In addition, there is no evidence suggesting that fertility problems are a side effect of any vaccine. People who are trying to become pregnant now or who plan to try in the future may receive the COVID-19 vaccine when it becomes available to them but it’s always prudent to consult with your doctor. Myth: The COVID-19 vaccine was developed to control the general population either through microchip tracking or "nanotransducers" in our brains. Fact: There is no vaccine microchip, and the vaccine cannot track people or gather personal information into a database. Myth: The vaccines were developed and produced using fetal tissue. Fact: The vaccines do not contain fetal cells nor were fetal cells used in the production the Pfizer and Moderna vaccines. Johnson & Johnson used human cell lines or also known as cell cultures to grow the harmless adenovirus but did not use fetal tissue. These same cell lines have been used for other vaccines including hepatitis, chickenpox and rabies and have been around for years. Peter Gulick is an associate professor of medicine at Michigan State University, College of Osteopathic Medicine, and serves as adjunct faculty in the College of Human Medicine and the College of Nursing. Dr. Gulick is available to speak with media - simply click on his icon now to arrange an interview today. Peter Gulick is an associate professor of medicine at Michigan State University, College of Osteopathic Medicine, and serves as adjunct faculty in the College of Human Medicine and the College of Nursing. Dr. Gulick is available to speak with media - simply click on his icon now to arrange an interview today.
Fewer cars, but more fatalities - What's happening on America's pandemic roadways
Fewer vehicles are traveling on America's roadways during the ongoing coronavirus pandemic, but the number of fatal car crashes in 2020 increased exponentially compared to the same time period in 2019. UConn expert Eric Jackson, a research professor and director of the Connecticut Transportation Safety Research Center, and behavioral research assistant Marisa Auguste examined the increase in a recent essay published by The Conversation: Curious about traffic crashes during the pandemic, we decided to use our skills as a social scientist and a research engineer who study vehicle crash data to see what we could learn about Connecticut’s traffic deaths when the stay-at-home orders first went into place last March. A partnership between the Department of Transportation, local hospitals and the University of Connecticut discovered what many people intuitively knew: Traffic volume and multivehicle crashes fell significantly during the stay-at-home order. Statewide, daily vehicle traffic fell by 43% during the stay-at-home order compared to earlier in the year, while mean daily counts of multivehicle crashes decreased from 209 before the stay-at-home order to 80 during lockdown. What was unexpected, however, was the significant increase in single-vehicle crashes, especially fatal ones. During the stay-at-home period, the incidence rate of fatal single-vehicle crashes increased 4.1 times, while the rate of total single-vehicle crashes was also up significantly. Data about all crash types in the state, whether single- or multivehicle, tell a similar story. Although preliminary, police reports have placed the 2020 year-end total for traffic deaths at 308, a 24% increase from 2019. While the researchers said that it's unclear why this counterintuitive increase in fatalities on the roads has occurred, their advice to drivers? "Check your speed" and "don't drive angry." If you are a journalist looking to know more about this topic, let us help. Simply click on Eric Jackson’s icon to arrange an interview today.
